Zobrazeno 1 - 10
of 220
pro vyhledávání: '"R. Faggiani"'
Autor:
G. Mocci, G. Maconi, G. Cataletti, B. Mantia, M. Serio, A. Scarcelli, F.M. Onidi, C. Pagnini, M. Graziani, M. Di Paolo, G. Pranzo, I. Luppino, P. Paese, R. Monterubbianesi, R. Faggiani, A. Ferronato, B. Perini, E. Savarino, L. Binaghi, E. Schiavoni, D. Napolitano, F. Scaldaferri, A. Papa, R. Lorenzetti, R. Pica, A. Cocco, S. Rodino, L. Sebkova, C. Zampaletta, F. Gaiani, L. Fanigliulo, L. Allegretta, A. Cuomo, L. Donnarumma, N. Della Valle, G. Forti, M. Dore, E. Antonelli, G. Bassotti, C. Iannelli, G. Aragona, A. Lauria, S. Piergallini, R. Colucci, C. Meucci, P. Usai Satta, W. Elisai, A. Tursi
Publikováno v:
Digestive and Liver Disease. 55:S162-S163
Autor:
G Mocci, G Maconi, F M Onidi, G Cataletti, W Elisei, F Scaldaferri, R Lorenzetti, C Pagnini, A Scarcelli, M G Graziani, M C Di Paolo, G Pranzo, I Luppino, R Monterubbianesi, R Faggiani, A Ferronato, E Savarino, R Pica, A Cocco, S Rodino, L Sebkova, C Zampaletta, F Gaiani, L Fanigliulo, L Allegretta, A Cuomo, L Donnarumma, N Della Valle, G Forti, E Antonelli, G Bassotti, C Iannelli, G Aragona, A Lauria, S Piergallini, R Colucci, L Binaghi, C Meucci, A Papa, A Tursi
Publikováno v:
Journal of Crohn's and Colitis. 17:i635-i636
Background Current data about long-term use of vedolizumab (VDZ) in ulcerative colitis (UC) versus Crohn’s disease (CD) patients are limited. We aimed to assess whether there are differences in term of long-term efficacy and safety of VDZ in UC vs.
Publikováno v:
International Journal of Surgery Case Reports
Highlights • This is the first case described in literature of a double asynchronous isolated perforation of the duodenum. • Timing of diagnosis and treatment are described. • Radiologic findings are provided.
Background Isolated duodenal
Background Isolated duodenal
Autor:
L Cantoro, R Monterubbianesi, C Camastra, G Falasco, P Pantanella, R Cosintino, R Faggiani, G Fiorino
Publikováno v:
Journal of Crohn's and Colitis. 17:i377-i377
Background Diagnostic delay is a challenge in inflammatory bowel disease (IBD), more in Crohn’s disease (CD) than in ulcerative colitis (UC). Whether difficult access to healthcare facilities may be a cause of diagnostic delay is debated. Restricti
Publikováno v:
Canadian Journal of Gastroenterology, Vol 25, Iss 6, Pp 315-318 (2011)
BACKGROUND: Clarithromycin resistance has decreased the eradication rates of Helicobacter pylori.
Externí odkaz:
https://doaj.org/article/f64dd61997a8439a802803e931fa8afd
Autor:
A, Tursi, G, Mocci, A, Cuomo, L, Allegretta, G, Aragona, R, Colucci, N, Della Valle, A, Ferronato, G, Forti, F, Gaiani, M G, Graziani, R, Lorenzetti, F, Luzza, P, Paese, A, Penna, R, Pica, S, Piergallini, G, Pranzo, S, Rodino, A, Scarcelli, C, Zampaletta, C, Cicerone, A, Cocco, G, De' Angelis, L, Donnarumma, M, Franceschi, S, Gallina, G, Grasso, T, Larussa, I, Luppino, R, Faggiani, L, Fanigliulo, C, Pagnini, P, Perazzo, R, Sacco, L, Sebkova, S, Scorza, M, Serio, A, De Monti, M, Picchio, W, Elisei, G, Maconi
Publikováno v:
European review for medical and pharmacological sciences. 25(4)
Ustekinumab (UST) is an anti-IL12/23 antibody for the treatment of Crohn's Disease (CD). The aim of this study was to compare the efficacy and safety of UST in a large population-based cohort of CD patients who failed previous treatment with other bi
Autor:
R. Faggiani, Gianfranco Fanello, A. Cocco, G. Dimito, Diego Baiocchi, E. Mattei, Cristina Grossi, P. Fedeli, E. Di Giulio, G. Occhigrossi, Giacomo Forti, A. Forte, Cesare Hassan, R. Ballanti, F. Baldi, E. Capezzuto, Stefano Frontespezi, M.G. De Palo, V. Ceci, Marco Emilio Bazuro, Stefano Angeletti, Guido Costamagna, N. Altavilla, S. Brighi, A. Scozzarro, Alessandra Barca, V. D'Ovidio, Federico Iacopini
Publikováno v:
ESGE Days.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Paola Balestrieri, Simone Saibeni, L. Biancone, Cristina Bezzio, C. Camastra, R. Monterubbianesi, R. Cosintino, Maria Lia Scribano, G. Falasco, P. Pantanella, Annalisa Aratari, R. Faggiani, A. Tullio, Claudio Papi, B. Neri
Publikováno v:
Journal of Crohn's and Colitis. 15:S351-S352
Background Ustekinumab (UST) is increasingly used in Italy for the treatment of refractory Crohn’s disease (CD), however very few data concerning real-life experience has been reported. Therefore, the aim of this study was to assess the long-term e
Autor:
Paola Balestrieri, L. Biancone, Maria Lia Scribano, Cristina Bezzio, R. Faggiani, Simone Saibeni, R. Monterubbianesi, B. Neri, Claudio Papi, R. Cosintino, C. Camastra, Annalisa Aratari, A. Tullio, P. Pantanella, G. Falasco
Publikováno v:
Digestive and Liver Disease. 53:S129